Granzyme Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Granzyme Antibodies for research in understanding the mechanisms of immune response and apoptosis. Granzyme Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Granzyme proteins play a crucial role in the immune system, particularly in the cytotoxic activity of T cells and natural killer cells. Serine proteases induce apoptosis in target cells, making Granzyme essential for the elimination of infected or malignant cells. Understanding the function and regulation of Granzyme proteins advances the development of therapeutic strategies against cancer and autoimmune diseases. Researchers worldwide utilize Granzyme monoclonal antibodies to explore cellular mechanisms and pathways involved in immune responses. Current investigations focus on how Granzyme proteins interact with different cellular components and their impact on various disease states. The application of Santa Cruz Biotechnology monoclonal antibodies continues to drive discoveries in immunology and cell biology research, supporting scientists in their quest to understand complex immune system mechanisms.